Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ABI-007 trial cleared to continue

Oct. 30, 2002

Mitsubishi Pharma claims new tyrosine kinase inhibitors for cancer and other proliferative disorders

Oct. 29, 2002

NIH researchers identify novel thalidomide analogues

Oct. 29, 2002

IDM and Nemod to develop cancer immunotherapy products

Oct. 28, 2002

Antiangiogenic gene therapy enhances radiation-induced tumor vascular destruction

Oct. 28, 2002

Androgen receptor modulators prepared and tested at Ligand

Oct. 28, 2002

Two phase III trials of Xyotax in PS2 NSCLC patients to proceed

Oct. 28, 2002

Positive phase I results for Prima BioMed's dendritic cell-based therapy

Oct. 28, 2002

Novel antiproliferative agents prepared at Temple University

Oct. 25, 2002

Clofarabine enters phase I/II trial in combination with ara-C

Oct. 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...